Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
OtherPractice

Is 45 the new 50 in colorectal cancer screening?

Paul Fritsch, Clarence Wong and Michael R. Kolber
Canadian Family Physician October 2020, 66 (10) 743;
Paul Fritsch
Family medicine resident at the University of Calgary in Alberta.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarence Wong
Associate Professor in the Division of Gastroenterology at the University of Alberta in Edmonton.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Kolber
Professor with the PEER Group in the Department of Family Medicine at the University of Alberta in Edmonton.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

Should we lower the age at which average-risk patients commence colorectal cancer (CRC) screening from 50 to 45?

Bottom line

In developed countries, the incidence of CRC in persons younger than 50 years has increased by 20% to 30% in the past 20 years. However, the absolute risk increase is only 1 to 4 per 100 000 persons. Screening average-risk patients younger than 50 should not be encouraged at this time.

Evidence

  • There are population-based data on CRC incidence among those younger than 50 in developed countries, but no RCTs examining commencing screening at 45 years versus 50 years are available.

    • - In Canada, a study1 of those younger than 50 years, comparing 2015 with 1971, found an increased incidence of 1 to 2 per 100 000 (from 10 or 11 to about 12 per 100 000). The relative risk increase (RRI) was about 20%.

    • - In a study in Alberta2 among those 35 to 49 years old, comparing 2014 with 1995, incidence increased by 4 per 100 000 (from 13 to 17): RRI was about 30%.

      • — In those younger than 50 years, comparing 2017 with 2010,3 incidence increased by 1 per 100 000 (from 6 to 7): RRI was about 20%.

      • — Alberta number differences are due to different ages and time frames studied.

    • - In a US study,4 among those 40 to 49, comparing 2013 with 1992, incidence increased by 4 per 100 000 (from 18 to 22): RRI was about 25%.

  • Many developed countries report small annual increases in CRC rates in patients younger than 50 years.5

Context

  • Screening for CRC (between 50 and 75 years old) decreases CRC mortality but not overall mortality.6

  • Improving screening compliance between those 50 to 75 years old to 80% (currently 55% in Canada7) would prevent about 3 times as many CRCs at a third of the cost of early-age screening.8

  • Most CRCs (88% to 92%) occur in patients older than 50.3,9

  • The median age of CRC diagnosis has decreased from 72 years (2002) to 66 years (2016).9

  • In the United States, rectal cancer is the most common CRC subtype in those younger than 50.9

  • Generally, guidelines recommend screening for CRC in those aged 50 to 75.10,11

  • Options for screening with RCT evidence6: fecal occult blood testing or fecal immunochemical testing every 1 to 2 years, or sigmoidoscopy every 10 years.11

Implementation

Those older than 75 are unlikely to benefit from screening.6 For those 50 to 75, the decision should be personalized. Patients with substantial comorbidity or functional limitation are unlikely to benefit, as some programs (especially outside primary care)12 offer screening without considering comorbidity.13 Tools (eg, https://eprognosis.ucsf.edu) to help determine the effect of comorbidities and function on life expectancy14 can aid discussions. Fecal immune testing should only be used for asymptomatic patients,15 as it might delay definitive investigations in symptomatic patients.

Notes

Tools for Practice articles in Canadian Family Physician are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in Canadian Family Physician are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • Competing interests

    None declared

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Brenner DR,
    2. Heer E,
    3. Sutherland RL,
    4. Ruan Y,
    5. Tinmouth J,
    6. Heitman SJ,
    7. et al
    . National trends in colorectal cancer incidence among older and younger adults in Canada. JAMA Netw Open 2019;2(7):e198090.
    OpenUrl
  2. 2.↵
    1. Alberta Health Services, Health Standards, Quality and Performance Division, Analytics and Performance Reporting Branch.
    Health trends Alberta: colorectal cancer incidence time trends. Edmonton, AB: Alberta Health Services; 2017.
  3. 3.↵
    1. Liu EY,
    2. Wong CK
    . Increasing incidence of colorectal cancer in adults under age of 50 in Alberta. J Can Assoc Gastroenterol 2020;3(Suppl 1):33-4.
    OpenUrl
  4. 4.↵
    1. Murphy CC,
    2. Lund JL,
    3. Sandler RS
    . Young-onset colorectal cancer: earlier diagnoses or increasing disease burden? Gastroenterology 2017;152(8):1809-12.e3. Epub 2017 Apr 28.
    OpenUrl
  5. 5.↵
    1. Araghi M,
    2. Soerjomataram I,
    3. Bardot A,
    4. Ferlay J,
    5. Cabasag CJ,
    6. Morrison DS,
    7. et al
    . Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol 2019;4(7):511-8. Epub 2019 May 16. Erratum in: Lancet Gastroenterol Hepatol 2019;4(8):e8. Epub 2019 Jun 10.
    OpenUrlPubMed
  6. 6.↵
    1. Canadian Task Force on Preventive Health Care.
    Recommendations on screening for colorectal cancer in primary care. CMAJ 2016;188(5):340-8. Epub 2016 Feb 22.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Singh H,
    2. Bernstein CN,
    3. Samadder JN,
    4. Ahmed R
    . Screening rates for colorectal cancer in Canada: a cross-sectional study. CMAJ Open 2015;3(2):E149-57.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Ladabaum U,
    2. Mannalithara A,
    3. Meester RGS,
    4. Gupta S,
    5. Schoen RE
    . Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology 2019;157(1):137-48. Epub 2019 Mar 28.
    OpenUrl
  9. 9.↵
    1. Siegel RL,
    2. Miller KD,
    3. Sauer AG,
    4. Fedewa SA,
    5. Butterly LF,
    6. Anderson JC,
    7. et al
    . Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70(3):145-64. Epub 2020 Mar 5.
    OpenUrlPubMed
  10. 10.↵
    1. US Preventive Services Task Force,
    2. Bibbins-Domingo K,
    3. Grossman DC,
    4. Curry SJ,
    5. Davidson KW,
    6. Epling JW Jr,
    7. et al
    . Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2016;315(23):2564-75. Erratum in: JAMA 2016;316(5):545. Erratum in: JAMA 2017;317(21):2239.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Helsingen LM,
    2. Vandvik PO,
    3. Jodal HC,
    4. Agoritsas T,
    5. Lytvyn L,
    6. Anderson JC,
    7. et al
    . Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ 2019;367:l5515.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Powell AA,
    2. Saini SD,
    3. Breitenstein MK,
    4. Noorbaloochi S,
    5. Cutting A,
    6. Fisher DA,
    7. et al
    . Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration. J Gen Intern Med 2015;30(6):732-41. Epub 2015 Jan 21.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Saini SD,
    2. Vijan S,
    3. Schoenfeld P,
    4. Powell AA,
    5. Moser S,
    6. Kerr EA
    . Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ 2014;348:g1247.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Cruz M,
    2. Covinsky K,
    3. Widera EW,
    4. Stijacic-Cenzer I,
    5. Lee SJ
    . Predicting 10-year mortality for older adults. JAMA 2013;309(9):874-6.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Lee MW,
    2. Pourmorady JS,
    3. Laine L
    . Use of fecal occult blood testing as a diagnostic tool for clinical indications: a systematic review and meta-analysis. Am J Gastroenterol 2020;115(5):662-70.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Family Physician: 66 (10)
Canadian Family Physician
Vol. 66, Issue 10
1 Oct 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is 45 the new 50 in colorectal cancer screening?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Is 45 the new 50 in colorectal cancer screening?
Paul Fritsch, Clarence Wong, Michael R. Kolber
Canadian Family Physician Oct 2020, 66 (10) 743;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Is 45 the new 50 in colorectal cancer screening?
Paul Fritsch, Clarence Wong, Michael R. Kolber
Canadian Family Physician Oct 2020, 66 (10) 743;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Notes
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Tools for Practice

  • Water for weight loss
  • Topical combination products for facial acne
  • Budesonide bests COVID-19
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2022 by The College of Family Physicians of Canada

Powered by HighWire